Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Elixir Pharmaceuticals gets $17mm with private placement

Executive Summary

Elixir Pharmaceuticals (drugs to slow the aging process) has raised $17mm with a private placement of Series B shares to lead investors Arch Venture Partners, MPM Capital, and Oxford Bioscience Partners. Other existing investors also participated. With the second tranche, the company brought in another $19mm, for a total of $40.5mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies